Abstract
Two-dimensional sheet-like nanomaterial molybdenum disulfide (MoS(2)) has extensive potential applications in the biomedical field. Nevertheless, upon entering the body, MoS(2) tends to accumulate markedly in the liver, drawing increasing attention to its potential hepatotoxicity. In this study, we demonstrated that MoS(2) nanosheets exerted cytotoxic effects on the liver both in vitro and in vivo. Further exploration of the toxicity mechanism, utilizing genome-wide CRISPR-Cas9 screening and molecular biological techniques, uncovered that MST2 protein is crucial in mediating MoS(2)-induced cytotoxicity. Moreover, protein mass spectrometry and molecular dynamics simulation results indicated that MoS(2) directly binds to MST2 protein, thereby promoting its phosphorylation and activation. Subsequently, phosphorylated MST2 protein activates the Hippo signaling pathway, which in turn suppresses liver cell proliferation. Our in vivo experiments revealed that MST2 is indispensable for MoS(2)-induced impairment of liver regeneration in mice and disordered liver development in zebrafish. Meanwhile, the MoS(2)/MST2 axis was to found induce hepatocyte death via activation of autophagy dependent on LC3 protein. Collectively, this study provides a foundation for a comprehensive understanding of the biological behavior and hepatotoxicity of MoS(2), offering valuable insights for the safety assessment of nanomaterials and the rational design of future nanomedicines.